Ling Zhen, ClinChoice CEO
With Lilly's backing, a CRO with roots in China bags $150M round to fuel global growth
A renamed CRO with deep ties in the US and China has pulled in another round of capital.
ClinChoice, formerly Fountain Medical Development, has completed …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.